Exagen Inc reports results for the quarter ended in March - Earnings Summary

Exagen

12/05/2022 18:04

* Exagen Inc  XGN.OQ  reported a quarterly adjusted loss
of 60
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 61
cents per share.
    * Revenue fell 1.8% to $10.39 million from a year ago; 
analysts
expected $10.00 million. 
    * Exagen Inc's reported EPS for the quarter was a loss of 60
cents​.
    * The mean earnings estimate of analysts had fallen by
about 17.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Exagen Inc shares had fallen by 31.5% this quarter and
lost 52.7% so far this year.
    * The company reported a quarterly loss of $10.27 million.
    * Wall Street's median 12-month price target for Exagen Inc
is
$17.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 05:03 p.m.  ​All
figures in US dollars unless otherwise stated